Mediterranean Diet Aids Cardiovascular Health Measures in Children, Teens
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 24, 2024 -- Mediterranean diet (MedDiet)-based interventions aid some cardiovascular health measures among children and adolescents, according to a review published online July 12 in JAMA Network Open.
José Francisco López-Gil, Ph.D., from Universidad de Las Américas in Quito, Ecuador, and colleagues conducted a systematic literature review to assess the effects of MedDiet-based interventions on biomarkers of cardiometabolic health among children and adolescents.
Based on data from nine randomized controlled trials (577 participants; mean age, 11 years), the researchers found that MedDiet-based interventions were significantly associated with reductions in systolic blood pressure (mean difference, −4.75 mm Hg), triglycerides (mean difference, −16.42 mg/dL), total cholesterol (mean difference, −9.06 mg/dL), and low-density lipoprotein cholesterol (mean difference, −10.48 mg/dL), as well as increases in high-density lipoprotein cholesterol (mean difference, 2.24 mg/dL), compared to the control group. There were no significant associations seen for other biomarkers studied, including diastolic blood pressure, glucose, insulin, or homeostatic model assessment for insulin resistance.
"These findings highlight the relevance of Mediterranean diet–based interventions as a useful tool to optimize cardiometabolic health in children and adolescents," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-25 01:15
Read more
- 1 in 5 Americans' Drinking Water Tainted With PFAS Chemicals
- FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer
- Many Teens Using Protein Bars, Shakes to Boost Muscle
- Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
- FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
- FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions